Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Prescription Drugs

AuroMedics Pharma LLC: Pantoprazole Sodium for Injection Recalled for Glass Particulates

Agency Publication Date: February 8, 2018
Share:
Sign in to monitor this recall

Summary

AuroMedics Pharma LLC is recalling one lot (approximately 66,100 vials) of Pantoprazole Sodium for Injection, 40 mg. This prescription medication, used to treat acid reflux and stomach issues, was found to contain a piece of glass in one vial within the affected lot. Because this medication is administered by injection, the presence of glass poses a significant health risk; consumers should contact their healthcare provider or pharmacist immediately regarding this recall.

Risk

If a piece of glass is injected into the bloodstream, it can cause local irritation, inflammation, or more serious life-threatening events such as the blockage of blood vessels (embolism) in vital organs like the lungs or brain.

What You Should Do

  1. Check your medication to see if it is Pantoprazole Sodium for Injection, 40 mg per vial, with NDC 55150-202-00 and Lot Number CPO170035.
  2. Verify the packaging; the affected product is a single-dose glass vial manufactured in India for AuroMedics Pharma LLC.
  3. If you have this specific lot, stop using the product immediately and do not administer it.
  4. Contact your healthcare provider or pharmacist for guidance on alternative treatment and to report any adverse health effects.
  5. Return any unused vials from Lot CPO170035 to the pharmacy or place of purchase for a refund.
  6. Contact AuroMedics Pharma LLC for further instructions regarding the return process.
  7. For additional information or to report a complaint, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Healthcare provider consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Pantoprazole Sodium for Injection (40 mg per vial)
Model:
NDC 55150-202-00
Lot Numbers:
CPO170035

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 78696
Status: Resolved
Manufacturer: AuroMedics Pharma LLC
Sold By: hospitals; clinics; pharmacies
Manufactured In: India, United States
Units Affected: 66,100 vials
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.